Amigo AI Raises $11M Series A | $150M Investment Validates Grow Therapy
A health technology funding roundup covering our Series A alongside Grow Therapy.
Newsroom
Selected coverage and announcements from Concurrence, formerly Amigo AI.
Coverage reflects its publication date. Historical headlines retain the company name used by the publisher.
Read the story behind our new name01
Reporting and industry roundups published under our current and former names.
A health technology funding roundup covering our Series A alongside Grow Therapy.
A weekly industry roundup that includes our Series A in its funding coverage.
Coverage of Jay Shah’s appointment as chief medical advisor at Amigo AI.
A report on our Series A and the Digital Residency process used to train patient-facing clinical agents.
Coverage of our Series A funding. Subscription required.
Reporting on the announced Amigo–Eucalyptus partnership and planned use of AI health assistants in virtual care.
A seed-funding mention in the Pro Rata newsletter.
02
Company-issued releases distributed by newswire services, separate from media coverage.
Our company announcement introducing the Concurrence name and the next stage of our healthcare AI platform.
Our company-issued Series A announcement, distributed by Business Wire.
03
Investor commentary and paid features, with the relationship identified for each publication.
Madrona’s investment rationale and perspective on training clinical agents. Madrona is an investor in Concurrence.
A sponsored walkthrough of how Amigo builds and trains clinical agents. This is paid coverage, not independent validation.